OPKO Health, Inc. cash flow to debt ratio of -41.18% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

OPKO Health, Inc.'s free cash flow has increased -8.48% from $-208.50M last year to $-190.82M, signaling increasing performance

OPKO Health, Inc.'s debt to equity ratio is 0.33, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

OPKO Health, Inc.'s debt has decreased relative to shareholder equity from 0.37 last year to 0.33 today, signaling strengthened financials

OPKO Health, Inc. has negative EBITDA, making leverage ratio unreliable

OPKO Health, Inc.'s interest coverage ratio is -1.95, which means that the company struggles to meet interest obligations, signaling financial risk.

OPKO Health, Inc.'s profit margin has decreased (390.92%) in the last year from -7.46% to -36.64%, signaling decreasing performance

OPKO Health, Inc.'s short-term assets of $581.88M exceed its short-term liabilities of $146.68M

OPKO Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

OPKO Health, Inc.'s return on equity of -16.78%, is lower than 15.00%, indicating bad performance

OPKO Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

OPKO Health, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

OPKO Health, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

OPKO Health, Inc. has negative free cash flow, indicating cash burn

OPKO Health, Inc.'s yearly earnings has decreased 324.02% since last year from $-53.22M to $-225.68M, signaling decreasing performance

OPKO Health, Inc.'s yearly revenue has decreased -14.90% since last year from $713.14M to $606.88M, signaling decreasing performance

ROIC -10.90% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

OPKO Health, Inc.'s 3-year revenue CAGR of -15.45% is negative, indicating declining revenue over the past 3 years

OPKO Health, Inc. had revenue growth in only 1.00 out of 5 years, indicating inconsistent revenue performance

OPKO Health, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

OPKO Health, Inc. has insufficient data to evaluate this check.

OPKO Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

OPKO Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

OPKO Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

OPKO Health, Inc. is overvalued relative to its fair value price of -1.16 based on Earnings Fair Value model

OPKO Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

OPKO Health, Inc. has a price-to-book ratio of 0.77x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

OPKO Health, Inc. has a price-to-sales ratio of 1.59x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue